Ratios Uncovered: Breaking Down Intellia Therapeutics Inc (NTLA)’s Trailing Twelve Months Metrics

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

The price of Intellia Therapeutics Inc (NASDAQ: NTLA) closed at $8.50 in the last session, up 5.26% from day before closing price of $8.07. In other words, the price has increased by $5.26 from its previous closing price. On the day, 2.44 million shares were traded.

Ratios:

We take a closer look at NTLA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.90 and its Current Ratio is at 4.90. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.10.

On March 05, 2025, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $30.

JP Morgan Downgraded its Overweight to Neutral on February 28, 2025, whereas the target price for the stock was revised from $45 to $13.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 29 ’25 when Bhanji Muna sold 265 shares for $8.50 per share. The transaction valued at 2,252 led to the insider holds 19,203 shares of the business.

Clark Eliana sold 679 shares of NTLA for $6,104 on Mar 04 ’25. The EVP, Chief Technical Officer now owns 95,369 shares after completing the transaction at $8.99 per share. On Mar 04 ’25, another insider, BASTA JAMES, who serves as the EVP, General Counsel of the company, sold 2,572 shares for $8.99 each. As a result, the insider received 23,122 and left with 111,925 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 19.32 while its Price-to-Book (P/B) ratio in mrq is 1.13.

Stock Price History:

Over the past 52 weeks, NTLA has reached a high of $28.18, while it has fallen to a 52-week low of $5.90. The 50-Day Moving Average of the stock is 4.21%, while the 200-Day Moving Average is calculated to be -39.52%.

Shares Statistics:

A total of 103.54M shares are outstanding, with a floating share count of 97.48M. Insiders hold about 5.88% of the company’s shares, while institutions hold 91.91% stake in the company.

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.